Physician profile
Leon Katz
NPI 1205890977
$5,495.81
in general payments reported to CMS, 2019-2025
10 companies · $3,239 in 2025
The $3,239 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $834 · 2020: $280 · 2021: $126 · 2022: $193 · 2023: $523 · 2024: $301 · 2025: $3,239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,120 · Food and Beverage: $943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,120.00 |
| Food and Beverage | $943.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,814.83 | 2020-2025 | Wegovy |
| Intuitive Surgical, INC. | $498.05 | 2019-2020 | |
| Medtronic, INC. | $321.67 | 2019-2023 | Signia, Venaseal |
| Baxter Healthcare | $262.30 | 2019-2023 | Tisseel |
| Lilly USA, LLC | $254.24 | 2024-2025 | Zepbound |
| Ethicon US, LLC | $195.01 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $57.65 | 2023-2024 | Nascobal |
| W. L. Gore & Associates, INC. | $52.34 | 2019 | |
| Redhill Biopharma INC. | $23.50 | 2024 | Talicia |
| Currax Pharmaceuticals LLC | $16.22 | 2023 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.